Journal
CURRENT BREAST CANCER REPORTS
Volume 8, Issue 1, Pages 1-13Publisher
SPRINGER
DOI: 10.1007/s12609-016-0198-3
Keywords
Breast cancer; Tumor-infiltrating lymphocytes; Immunotherapy; Translational research
Categories
Ask authors/readers for more resources
Recent attention has focused on the antitumor immune response in breast cancer, in particular, the role of tumor-infiltrating lymphocytes (TILs). In certain breast cancer subtypes, the presence of TILs has prognostic value and is associated with clinical outcome and improved survival. The potential predictive value of TILs has also been investigated in regard to cytotoxic and antihuman epidermal growth factor receptor 2 (HER-2) therapies, but could also serve as a selection marker for novel immunotherapies. In this article, we review the current literature on TILs in breast cancer and discuss how TILs are emerging as a promising biomarker in mediating antitumor immunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available